Predictive Factors of Stent Patency in Iliofemoral Venous Diseases in a Multicentre Cohort Study

医学 血栓后综合征 中止 外科 深静脉 血栓形成 支架
作者
O. Espitia,Frédéric Douane,Jeanne Hersant,Fabrice Abbadie,Jonathan Sobocinski,Jean-François Heautot,Annaïg Miossec,François-Xavier Lapébie,Olivier Hartung
出处
期刊:European Journal of Vascular and Endovascular Surgery [Elsevier BV]
卷期号:65 (4): 564-572 被引量:6
标识
DOI:10.1016/j.ejvs.2023.01.005
摘要

This study assessed primary stent patency predictive factors in three groups of patients with history of lower limb (LL) vein thrombosis: non-thrombotic iliac vein lesion (NIVL), acute deep vein thrombosis (aDVT), and post-thrombotic syndrome (PTS).Consecutive patients from January 2014 to December 2020 with history of LL vein stenting from seven hospitals were included. All patients received an iliac or common femoral venous stent and had at least a six month follow up available with stent imaging. Anticoagulant and antiplatelet therapy strategies employed after venous stenting are reported and compared between groups.This study included 377 patients: 134 NIVL, 55 aDVT, and 188 PTS. Primary patency was statistically significantly higher in the NIVL group (99.3%) compared with the PTS group (68.6%) (p < .001) and the aDVT group (83.6%) (p = .002). PTS patients received a statistically significantly greater number of stents (p < .001) and had more stents below the inguinal ligament (p < .001). Median follow up was 28.8 months (IQR 16, 47). Discontinuation of antiplatelet therapy at the last assessment was 83.6% for NIVL, 100% for aDVT, and 95.7% for the PTS group (p < .001). Discontinuation of anticoagulation therapy at the last assessment was 93.2% for NIVL, 25.0% for aDVT, and 70.3% for the PTS group (p < .001). The only predictor of worse primary patency in the aDVT group was long term anticoagulation before stenting.Patients with NIVL have better primary patency after venous stenting than patients with venous thrombotic disorders. Long term anticoagulation before stenting was the only factor associated with poorer primary patency in patients with aDVT.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
昏睡的冰枫完成签到 ,获得积分10
1秒前
zyc发布了新的文献求助10
1秒前
布二发布了新的文献求助10
2秒前
2秒前
SciGPT的应助被小蝴蝶采纳,获得10
3秒前
3秒前
3秒前
5秒前
5秒前
6秒前
天才抱妹噜完成签到 ,获得积分10
6秒前
123完成签到,获得积分10
6秒前
orixero的应助被ggk采纳,获得10
7秒前
科研通AI6.4的应助被王宇洁采纳,获得10
7秒前
Akim的应助被ZY采纳,获得10
7秒前
传统的白风完成签到 ,获得积分10
7秒前
踏实博超发布了新的文献求助10
9秒前
10秒前
10秒前
青铜时代完成签到,获得积分10
10秒前
11秒前
Aaron567发布了新的文献求助10
12秒前
12秒前
13秒前
蒋y完成签到,获得积分10
13秒前
han完成签到,获得积分10
14秒前
14秒前
14秒前
科研通AI6.2的应助被快别闹了采纳,获得10
15秒前
水煮电吹风的应助被Redream采纳,获得10
16秒前
zyc完成签到,获得积分10
17秒前
汤包发布了新的文献求助10
17秒前
wu发布了新的文献求助10
18秒前
18秒前
科研通AI6.3的应助被一见喜采纳,获得10
19秒前
辉煌发布了新的文献求助10
20秒前
20秒前
雅风发布了新的文献求助10
21秒前
玉米红豆卷完成签到 ,获得积分10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183739
求助须知:如何正确求助?哪些是违规求助? 9572996
关于积分的说明 21828615
捐赠科研通 7780904
什么是DOI,文献DOI怎么找? 3434101
关于科研通互助平台的介绍 2558294
邀请新用户注册赠送积分活动 2480564